Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Dehaier Medical Systems goes public: Developer of medical devices for the Chinese market goes public through a $12 million offering of 1.5 million shares at $8 each, completed April 22. The firm assembles branded products at its Beijing facility from components made by third parties, and also distributes finished products made by other companies. Offerings include x-ray, anesthesia and patient monitoring systems, as well as home respiratory and oxygen products. Proceeds from the initial public offering are tabbed for R&D, marketing, potential acquisitions and working capital. The shares trade on the Nasdaq exchange under the symbol "DHRM." Anderson & Strudwick was placement agent for the offering
You may also be interested in...
Spine Deal Redux: Alphatec Makes Another Go At Acquiring Scient'x
Alphatec Spine aims to significantly expand its international sales presence and create the third-largest independent spinal device firm through its $116 million acquisition of French spinal implant company Scient'x
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.